Clinical Trial Update: A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

This clinical trial update reports on a completed pilot study evaluating whey protein supplementation for non-alcoholic fatty liver disease and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Whey protein supplement (whey protein)

Snippet

Sponsor: University of Lausanne | Conditions: Non-alcoholic Fatty Liver Disease, Obesity | NA | Status: COMPLETED